The rational use of influenza vaccines in healthy children and children with underlying conditions

Current Opinion in Infectious Diseases

Volumn 22, Issue 3, 2009, Pages 244-249

  Esposito, Susanna ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Children; Influenza; Influenza vaccination; Prevention; Vaccine

Indexed keywords

INFLUENZA VACCINE;

COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HUMAN; INFLUENZA; PEDIATRICS; REVIEW; SOCIOECONOMICS; VIRUS ATTENUATION; VIRUS INACTIVATION; CHILD; IMMUNOLOGY; INFANT; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 65549123954     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32832a58e4     Document Type: Review

References (55)

1. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Morb Mortal Wkly Rep 2008; 57 (RR07): 1-59. A primary source of information on recommendations for the use of influenza vaccine and antiviral agents.
2. Nicoll A, Ciancio B, Tsolova S, et al. The scientific basis for offering influenza immunisation to risk groups in Europe. Euro Surveill 2008; 13pii:19018. This study summarizes the scientific evidence supporting the selection of risk groups that would benefit from annual seasonal influenza immunization in the European Union.
3. Esposito S, Marchisio P, Principi N. The global state of influenza in children. Pediatr Infect Dis J 2008; 27 (11 Suppl):S149-S153. A review that evaluates the impact of influenza on pediatric patients and that shows why influenza vaccination should be more widely used than is usually recommended in European countries.
4. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342:232-239.
5. Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits and courses of antibiotics in children. N Engl J Med 2000; 342:225-231.
6. Bhat N, Wright JG, Broder KR, et al. Influenza associated deaths among children in the United States: 2003-2004. N Engl J Med 2005; 353:2559-2567.
7. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122:805-811. This study describes influenza-associated pediatric mortality in the USA from 2004 to 2007, including an increase of Staphylococcus aureus coinfections.
8. Schrag SJ, Shay DK, Gershman K, et al. Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003-2004. Pediatr Infect Dis J 2006; 25:395-400.
9. Jansen AG, Sanders EA, Hoes AW, et al. Influenza- and respiratory syncytial virus-associated mortality and hospitalizations. Eur Respir J 2007; 30:1158-1166.
10. Coffin SE, Zaoutis TE, Rosenquist AB, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 2007; 119:740-748.
11. Lewis EN, Griffin MR, Szilagyi PG, et al. Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit. Pediatrics 2007; 120:467-472.
12. Newland JG, Laurich VM, Rosenquist AW, et al. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr 2007; 150:306-310.
13. Centers for Disease Control and Prevention (CDC). Influenza activity: United States and worldwide, 2007-08 season. MMWR Morb Mortal Wkly Rep 2008; 57:692-697. This study describes influenza activity in the USA and worldwide during the season 2007-2008, with incidence data in relation to age group.
14. Sebastian R, Skowronski DM, Chong M, et al. Age-related trends in the timeliness and prediction of medical visits, hospitalizations and death due to pneumonia and influenza, British Columbia, Canada, 1998-2004. Vaccine 2008; 26:1397-1403. This study evaluates the age groups associated with the earliest seasonal influenza activity and which may have the greatest indirect impact at population level.
15. Bourgeois FT, Valim C, Wei JC, et al. Influenza and other respiratory virusrelated emergency department visits among young children. Pediatrics 2006; 118:e1-e8.
16. Gasparini R, Durando P, Ansaldi F, et al. Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains. Eur J Clin Microbiol Infect Dis 2007; 26:619-628.
17. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355:31-40.
18. Marchetti M, Kühnel U, Colombo G, et al. Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age. Hum Vaccines 2007; 3:14-22.
19. World Health Organization Consultation on the Composition of Influenza Vaccine for the Northern Hemisphere 2008-2009. Available at http://www.who.int/ csr/disease/influenza/vaccine-north2008-9/en/.
20. Vesikari T. Emerging data on the safety and efficacy of influenza vaccines in children. Pediatr Infect Dis J 2008; 27 (11 Suppl):S159-S161. An article on the different influenza vaccines that can be used in children, and the efficacy of live-attenuated intranasal influenza vaccine.
21. Glezen WP. Clinical practice. Prevention and treatment of seasonal influenza. N Engl J Med 2008; 359:2579-2585. A study with a description of a clinical case of death due to influenza and Staphylococcus aureus coinfection in a previously healthy adolescent and a discussion on the prevention and treatment of seasonal influenza.
22. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685-696. [Erratum in N Engl J Med 2007; 356:1283].
23. Hibbert CL, Piedra PA, McLaurin KM, et al. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine 2007; 25:8010-8020.
24. Glezen PW. Universal influenza vaccination and live attenuated influenza vaccination of children. Pediatr Infect Dis J 2008; 27:S104-S109. This review explains why the systematic delivery of influenza vaccine in school-based and workplace-based clinics would greatly enhance the control of epidemic influenza and help prepare for the next pandemic.
25. Halasa NB, Gerber MA, Chen Q, et al. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis 2008; 197:1448-1454. This prospective, open-label study evaluates the safety and immunogenicity of trivalent inactivated influenza vaccine in healthy infants aged 10-22 weeks.
26. Vesikari T, Karvonen A, Smith HM, et al. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age. Pediatrics 2008; 121:e568-e573. This study evaluates the safety and tolerability of cold-adapted influenza vaccine, trivalent, administered intranasally to healthy children aged from 6 to less than 24 weeks.
27. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization on mothers and infants. N Engl J Med 2008; 359:1555-1564. This study assesses the clinical effectiveness of inactivated influenza vaccine administered during pregnancy in Bangladesh.
28. Jefferson T, Smith S, Demicheli V, et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005; 365:773-780.
29. Manzoli L, Schioppa F, Boccia A, Villari P. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J 2007; 26:97-106.
30. Esposito S, Marchisio P, Bosis S, et al. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years. Vaccine 2006; 24:629-635.
31. Fleming DM, Elliot AJ. Health benefits, risks, and cost-effectiveness of influenza vaccination in children. Pediatr Infect Dis J 2008; 27 (11 Suppl): S154-S158. This study reviews issues surrounding the epidemiology of influenza and vaccine effectiveness relevant to the determination of vaccination policy.
32. Zerr DM, Englund JA, Robertson AS, et al. Hospital-based influenza vaccination of children: an opportunity to prevent subsequent hospitalization. Pediatrics 2008; 121:345-348. This study shows that hospital-based influenza vaccination programs can reach children at the highest risk of influenza complications and reduce the rates of pediatric hospitalizations for the treatment of influenza-related illness.
33. Szilagyi PG, Fairbrother G, Griffin MR, et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a casecohort study. Arch Pediatr Adolesc Med 2008; 162:943-951. A study that measures vaccine effectiveness in preventing influenza-related healthcare visits in children aged 6-59 months during two consecutive influenza seasons.
34. Eisenberg KW, Szilagyi PG, Fairbrother G, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008; 122:911-919. A study that estimates the effectiveness of influenza vaccination against laboratory-confirmed influenza during the 2003-2004 and 2004-2005 influenza seasons in children aged 6-59 months.
35. Savidan E, Chevat C, Marsh G. Economic evidence of influenza vaccination in children. Health Policy 2008; 86:142-152. A review of published economic evaluations of influenza vaccinations for children, including direct individual and indirect social benefits.
36. Wright PF, Sannella E, Shi JR, et al. Antibody responses after inactivated influenza vaccine in young children. Pediatr Infect Dis J 2008; 27:1004-1008. This study evaluates the frequency and duration of antibody responses to trivalent inactivated influenza vaccine in children aged 6-23 months.
37. Vesikari T, Fleming DM, Aristegui JF, et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 2006; 118:2298-2312.
38. Tam JS, Capeding MR, Lum LC, et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 2007; 26:619-628.
39. Rhorer J, Ambrose CS, Dickinson S, et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine 2009; 27:1101-1110. This study describes the results of nine randomized clinical trials (involving approximately 25 000 children aged 6-71 months and 2000 children aged 6-17 years) evaluating the efficacy of live-attenuated influenza vaccine against culture-confirmed influenza in comparison with placebo or trivalent inactivated vaccine.
40. Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 2006; 25:870-879.
41. Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006; 25:860-869.
42. Gaglani MJ, Piedra PA, Riggs M, et al. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr Infect Dis J 2008; 27:444-452. A study of the safety of the intranasal, trivalent, live-attenuated influenza vaccine in healthy children aged 1.5-18 years with a history of intermittent wheezing.
43. Miller EK, Griffin MR, Edwards KM, et al. Influenza burden for children with asthma. Pediatrics 2008; 121:1-8. A study of influenza disease burden in healthy and asthmatic children based on active, laboratory-confirmed, population-based surveillance.
44. Esposito S, Gasparini C, Martelli A, et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Vaccine 2008; 26:4664-4668. A study demonstrating the safety of influenza vaccination with inactivated virosomal adjuvanted vaccine in asthmatic children with egg allergy.
45. Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among children aged 6-23 months: United States, 2006-07 influenza season. MMWR Morb Mortal Wkly Rep 2008 26; 57:1039-1043. A study on influenza vaccination coverage among children aged 6-23 months in the USA during the 2006-2007 influenza season.
46. Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among children aged 6-59 months - eight immunization information system sentinel sites, United States, 2007-08 influenza season. MMWR Morb Mortal Wkly Rep 2008 26; 57:1043-1046. A study on influenza vaccination coverage among children aged 6-59 months in the USA during the 2007-2008 influenza season.
47. Mereckiene J, Cotter S, Nicoll A, et al. National seasonal influenza vaccination survey in Europe 2008. Euro Surveill 2008; 13pii:19017. A cross-sectional survey undertaken in European Union Member States, Norway, and Iceland to describe seasonal influenza immunization in the 2006-2007 season, identify country-specific recommendations for risk groups, obtain vaccine uptake information, and allow comparison with global recommendations.
48. Murris-Espin M, Aubert M, Bosdure E, Dubus JC. Influenza vaccination coverage in patients with cystic fibrosis followed at 12 care centers in the Greater South Region of France for the season 2005/2006. Vaccine 2008; 26:5612-5618. An observational study that estimates influenza vaccination coverage in the 2005/2006 season in cystic fibrosis patients attending 12 cystic fibrosis care centers.
49. Cho BH, Kolasa MS, Messonier ML. Influenza vaccination coverage rate among high-risk children during the 2002-2003 influenza season. Am J Infect Control 2008; 36:582-587. A study on the characteristics of influenza vaccination coverage among high-risk children in the USA during the 2002-2003 influenza season.
50. Nakamura MM, Lee GM. Influenza vaccination in adolescents with high-risk conditions. Pediatrics 2008; 122:920-928. This study assesses influenza vaccination rates from 1992 to 2002, individual vaccination continuity, and missed opportunities for vaccination in adolescents with high-risk conditions.
51. Esposito S, Tremolati E, Bellasio M, et al. Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children. Vaccine 2007; 25:5283-5289.
52. Esposito S, Bosis S, Pelucchi C, et al. Influenza vaccination among healthcare workers in a multidisciplinary University hospital in Italy. BMC Public Health 2008; 8:422. This study evaluates the current vaccination status and knowledge of influenza among the healthcare workers in one of Italy's largest multidisciplinary university hospitals.
53. Centers for Disease Control and Prevention (CDC). Immunization information systems progress: United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:289-291. This study highlights selected data from the CDC's 2006 Immunization Information System Annual Report (IISAR), a survey of grantees in 50 states, five cities, and the District of Columbia receiving funding under the Public Health Service Act.
54. Esposito S, Pelucchi C, Tel F, et al. Factors conditioning effectiveness of a reminder/recall system to improve influenza vaccination in asthmatic children. Vaccine 2009; 27:633-635. This study evaluates whether a telephone recall system directly managed by the pediatricians who usually follow up children for their asthma is more effective than an anonymous recall system.
55. Bexelius C, Merk H, Sandin S, et al. SMS versus telephone interviews for epidemiological data collection: feasibility study estimating influenza vaccination coverage in the Swedish population. Eur J Epidemiol 2009; 24:73-81. This study compares the use of the mobile phone short message service (SMS) with that of telephone interviews in collecting self-reported data concerning influenza vaccination.